EMD-38692

Single-particle
3.7 Å
EMD-38692 Deposition: 14/01/2024
Map released: 27/03/2024
Last modified: 12/06/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-38692

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8xv5 summary report (pdf.gz) Map-8xv5 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Pyridoxamine-bound human SLC19A3

EMD-38692

Single-particle
3.7 Å
EMD-38692 Deposition: 14/01/2024
Map released: 27/03/2024
Last modified: 12/06/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: human SLC19A3 in complex with pyridoxamine
Fitted models: 8xv5

Deposition Authors: Dang Y, Wang GP, Zhang Z
Substrate and drug recognition mechanisms of SLC19A3.
Dang Y, Zhang T, Pidathala S , Wang G, Wang Y, Chen N , Song C , Lee CH , Zhang Z
(2024) Cell Res , 34 , 458 - 461
PUBMED: 38503960
DOI: doi:10.1038/s41422-024-00951-2
ISSN: 1001-0602